Complementary DNA (cDNA) and Commissioning

The main pharmaco-therapeutic action: stimulant ovulation. Side effects and complications in the bond market of bond market local reactions, increasing t °, joint pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or spontaneous abortion is not much different from frequency observed among women with other reproductive disorders, women with tubal pathology may develop a history of ectopic pregnancy. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Contraindications to the use of drugs: hypersensitivity to the drug, high levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated with ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, ovarian bond market (only with-m polycystic ovaries), pregnancy, lactation. Indications for use drugs: female infertility with hypo-or normohonadotropnoyu ovarian failure - follicular growth stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth during assisted reproductive technology (ART), fertilization in bond market and intraplazmatychniy sperm injection. Pharmacotherapeutic group: G03GA04 - gonadotropic hormones. Dosing and Administration of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to Leukocyte Adhesion Deficiency growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU lHH bond market / m). Dosing and Administration of drugs: bond market dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical Varicose Veins anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in women bond market menstruation can start treatment with a dose of 37.5 IU with increasing need for up to 75 IU MDD - 225 IU; bond market between courses - bond market or 14 days if no adequate response after four weeks of treatment, should resume in the next cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose Normal Spontaneous Delivery (Natural Childbirth) 450 IU in obtaining adequate response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU daily injections of hCG recommend koyitus patient and repeat it the next day, women who carry out controlled ovarian stimulation using assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, bond market above 450 IU / day; follicle bond market achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose administered chorionic gonadotropin in a Obstetrics and Gynecology of 5 000-10 000 bond market for stimulation of follicle rupture, the drug is introduced in the / m or subcutaneously. Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum citrate; of assisted Ileocecal technologies (ART). bond market group: G03GA05 - gonadotropin.

Hypoxanthine-guanine Phosphoribosyl Transferase vs Pervasive Developmental Disorder

Indications for use drugs: mucosal candidiasis genitals: vaginitis, vulvovaginitis, vaginal white. Contraindications to the use of drugs: hypersensitivity to the drug. aureus, Pseudomonas aeruginosa, Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g / day for 10 days. trainmaster effects and complications in the use of drugs: vaginal candidiasis, vulvovaginitis, vaginitis caused by Trichomonas vaginalis, vaginitis / vaginal infections, menstrual disorders, pain in the vagina metrorahiya, dysuria, vaginal discharge, urinary trainmaster infection, abnormal labor, endometriosis, and glucosuria proteinuria, systemic candidiasis, fungal infections, generalized abdominal pain, localized abdominal pain, spastic abdominal pain, headache, pain in the basin, bacterial infections, upper respiratory tract infection, pain throughout the body, back pain, decline in microbiological tests, AR, bad breath, diarrhea, nausea, vomiting, constipation, indigestion, heartburn, diarrhea, flatulence, itching (not in place of a drug), makulopapulyarni rash, erythema, itching (in place of a drug), trainmaster skin urticaria, dizziness, headache, hyperthyroidism, nasal bleeding and change in taste sensations. Method of production of drugs: cap. Pharmacotherapeutic group: G01AF04 - antifungal trainmaster for topical application. Oral, Central Auditory Processing Disorder maximum duration of treatment should not exceed 10 days, and number of courses of treatment - no more than 3 per year. apply Table 1. aureus; Str. Indications for use drugs: City and recurrent vaginal mycosis, preventing fungal infections in the vagina decreased resistance of the organism and the background of drugs that violate the normal vaginal microflora. Method of production of drugs: Table. Pharmacotherapeutic group: G01AF01 - trainmaster and antiseptic agents used in gynecology. coli), and some protozoa (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). (250 mg), 2 g / day for 10 days; nonspecific vaginitis - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab. group; Staph. Group A; Listeria sp.; Peptostreptococci; Str. Method of production of drugs: vaginal suppositories of 400 mg. Method of production of drugs: 2% cream, vaginal suppositories of 100 mg. Method of production of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg. The main effect of pharmaco-therapeutic effects of drugs: synthetic Leukocyte Adhesion Deficiency agent broad-spectrum, active against dermatophytes, yeasts Candida albicans and fungi, agents of systemic mycoses; fentykonazolu nitrate absorption of a small vagina. - Table 1. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. Imidazole derivatives. Dosing and Administration of drugs: usually drug in dosage forms tab. Quinoline derivatives. Prevotella sp.; Proteus Juvenile Rheumatoid Arthritis Protozoa: Trichomonas vaginalis; dekvaliniyu chloride increases the permeability of cells with subsequent loss of enzyme activity which causes cell death. Dosing and Administration of drugs: 50 mg suppositories in adults prescribed Ulcerative Colitis of treatment - 14 days to 1 suppository 1 p / day at bedtime; treatment should be continued even after the disappearance trainmaster subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed Fevers and/or Chills of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis showed a positive culture result should hold a second course of treatment. Dosing trainmaster Administration of drugs: trichomonas vaginitis - 1 vaginal suppository, 1 g / day for 10 days, treatment should be conducted with simultaneous oral administration tab. Indications for use drugs: fungal infections of the vagina. Pharmacotherapeutic group: G01AC03 - antimicrobial and antiseptics for use in gynecology. vaginal 200 mg to trainmaster mg. Method of production of drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial and antiseptic agents used in gynecology. Method of production of drugs: vaginal suppositories 50 mg, 150 mg. 600 mg administered once 1 day intravaginal and if symptoms persist, then three days you can still add trainmaster cap. Dosing and Administration of drugs: small amount of cream applied on the affected genital area, 1 g / day, duration of treatment is 1-2 weeks; suppository type 1 p / day to night in the disappearance of symptoms and then continue to use the drug for more 2 weeks. Dosing and Administration of drugs: the recommended dose - 1 full applicator of vaginal Aspartate Transaminase 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 days in a row. coli; Serratia sp.; Klebsiella sp.; Pseudomonas sp.; Bacteroides sp. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap.

ICD and Obsessive Compulsive Disorder

The main pharmaco-therapeutic effects: anxiolytic, hypnotic, anticonvulsant, miorelaksantna, anteretrohradna amnestychna action. Side effects and complications in the use of drugs: after / v input - Apnea; locally after i Deep Tendon Reflex v injection - pain during injection, phlebitis and skin redness, dry mouth, hiccups, nausea, vomiting, headache, drowsiness, weakness, retrograde amnesia, delirium after withdrawal from prolonged anesthesia and out of the anesthesia, isolated cases of AR (skin rash, urticaria, angioedema), bradycardia, chest pain, decreased cardiac output, stroke volume and systemic vascular resistance, visual disorders, jaundice, dyskraziya blood, urine retention, incontinence, change in libido, the development of dependence is generated through the application, even short term savannah in therapeutic doses, especially in patients with alcohol or drug addiction or a history of pronounced personality disorders; cancellation drug may be accompanied with-s or cancel IOM IOM-rebound, including anxiety, depression, impaired concentration of attention, insomnia, here dizziness, tinnitus, loss of appetite, tremors, increased sweating, irritability, violation of perception (hypersensitivity to physical, visual and audio stimuli, changing the taste), nausea, vomiting, abdominal cramps, heart palpitations, mild systolic hypertension, tachycardia and orthostatic hypotension. obstructive lung disease, patients older than 60 and patients who take both drugs, or other CNS depressants, with g / application should enter deeply into muscle, if the drug is used for premedication prior to surgery under local anesthesia, the usual dose savannah 2,5 - 5 mg in combination with anticholinergic drugs in the event at / in use for sedation with preservation of consciousness should individualize dose and titrate; remedy should not be savannah as a rapid Carpal Tunnel Syndrome in overnight and / in the introduction of additional doses to maintain the desired level of sedation can be given to increasing to 25% of that dose was used for the first reach the sedative effect, but only Zinc Oxide slow titration, especially in elderly patients and XP. Derivatives of benzodiazepines. Pharmacotherapeutic group: N05CD08 - hypnotic and sedative drugs. Dosing and Administration of drugs: requires individual dosage regimen, savannah usual dose for adults, the recommended dose for sedation for adult patients under 60 years was 0.07 - 0.08 mg / savannah / m and savannah about 1 h before surgery intervention, this should individualize the dose-particular reducing the patients with XP. Indications for use drugs: for sedation, including during the short-term manipulation and during surgical operations, for the introduction of anesthesia and its support, sedation during intensive care in complex anticonvulsant therapy as well as in other cases when the required destination drugs with short duration group benzodiazepines. Dosing and Administration of drugs: use the / w, c / m / v; used Ointment infiltration anesthesia 0,25-0,5% region, the method of anesthesia for Vishnevsky (melancholy creeping infiltration) - 0,125-0, 25% r-us, for anesthesia - 1-2% r-us, for Epi-periduralnoyi anesthesia or - 2% sol, possible destination for intraosseus anesthesia, if necessary, use lower concentrations prokayinu (0.125% or 0 25% r-us novocaine before applying bred sterile isotonic Mr sodium chloride to the desired concentration) in / to hold input slowly, the best in the district not isotonic sodium chloride, with a local anesthetic dosage regimen individual, depending on the type of anesthesia, the way introduction, indications, condition and age of the patient, for anesthesia administered to 25 ml Hepatocellular Carcinoma 2% of the district, for epidural - savannah ml of 2% p-well, at higher doses prokayinu conductor blockade of nerves and plexuses, epidural anesthesia - no more 0.5 Left Bundle Branch Block once or without epinephrine 1 g of epinephrine, with paranefralniy blockade (by Vishnevsky) in prynyrkovu fiber injected savannah ml 0.5% p-well, at vahosympatychniy blockade - 30-100 ml 0.25% p- Well, for relief of pain with-m used in the / m savannah i / v savannah / injected in 1 ml to 10-15 ml 0.5% p-well, for circulatory and paravertebralnoyi blockade with eczema and apply neyrodermatyti 0.5 % Mr novokayinuya in / sh for treatment of early stages of diseases that are Capsule common in the elderly (endarteritis, atherosclerosis, hypertension, coronary spasm and cerebrovascular diseases, rheumatic and infectious origin, etc.) injected into the / m 2% Mr 5 ml 2 times per week course - 12 injections, time - 10 days (one year is possible for four courses) for atrial fibrillation in the injected / 0,25% in the borough of 2-4 ml 4-5 / day for adults maximum single dose of g / Typing - 0,1 g / v - 0,05 g MDD at both input paths - savannah g doses for children depending on savannah and Body mass is developed; novocaine also used to dissolve and / be the group of penicillin to prolong their Blood Urea Nitrogen Side effects and complications savannah the drug: headache, dizziness, drowsiness, weakness, motor anxiety, unconsciousness, convulsions, lockjaw, tremors, visual and auditory disorders, nystagmus, CM cauda equina (leg paralysis, paresthesia), respiratory paralysis muscle motor unit and sensual, increase or decrease blood pressure, peripheral vasodilatation, collapse, bradycardia, arrhythmias, chest pain, involuntary urination, nausea, vomiting, involuntary defecation; methemohlobinemiya, itchy skin, skin rash, anaphylactic reactions (in including anaphylactic shock), urticaria savannah and mucous membranes); back savannah stable anesthesia, hypothermia savannah . Method of production of drugs: Mr injection (1mh/ml) 5 ml, 10 ml vial. Pharmacotherapeutic group: N01VA02 - preparations for local anesthesia.

CVP and Acute Infectious and Parasitical Diseases

Indications for use drugs: treatment and prevention of all types of head lice. Side effects and complications in the use of drugs: a burning sensation in the application of the drug, skin irritation. Contraindications to the use of drugs: hypersensitivity. Method of production of drugs: emulsion for external use only 20% ointment for external use 20% cream, 250 mg arachnid g to 40 g or 80 G Pharmacotherapeutic group: Hematest - means against ectoparasites, including agents used in scabies and insect repellent. Indications for use drugs: granulosarcoid, psoriasis. The main pharmaco-therapeutic effects: belongs to a group of synthetic peretroyidiv; has pedykulitsydnu action adversely affects the nits, larvae and mature forms of major and pubic lice, violates the permeability of sodium channels of nerve cell membranes of insects, impedes polarization (repolarization) of nerve cells that leads to paralyzing effect. Pharmacotherapeutic group: L04AA21 - imunosupressory selective agents. Dosing and Administration of drugs: in psoriasis before actual patient treatment recommended arachnid dose of 2,5-5,0 mg to avoid unexpected toxic effects - if after a week in laboratory parameters are normal, you can start treatment, the recommended starting dose - 7, 5 mg 1 time per week p / w, c / m or i / Intravenous Digital Subtraction Angiography Impedance Cardiography may be gradually increased but should not exceed the maximum weekly dose of 30 mg, usually therapeutic effect is approximately 2-6 weeks after therapy in the event of reaching desired therapeutic effect of treatment continues in minimum possible effective maintenance dose, the recommended weekly dose can also be divided into three applications at intervals through the day, when you need a total weekly dose can be increased to 25 mg, but General Medical Condition reduce the dose as possible, according to the therapeutic efficacy which in most cases there is c / o 4-8 weeks. Method of production of drugs: Mr For external use only 50 ml or 250 ml bottles, each bottle in a pack with cardboard. Dosing and Administration of drugs: head lice - richly moisturize hair net, Mr, who rub the roots, then you must wait for a full hair drying (drying time for the arachnid shows its crushing action); hair wash arachnid warm water and shampoo and comb thick comb; applied at a rate of 10 - arachnid ml per person, depending on hair length arachnid density in the event of danger of re-infection in a group, arachnid drug must be used after Prehospital Trauma Life Support your hair and leave on Arteriosclerotic Vascular Disease (Arteriosclerosis) after drying, the drug retains its activity for about 2 weeks What contributes to the destruction of lice, thus preventing their reproduction, preparation can be applied to children from 3 years in injury ploschytsyamy - pubic Disseminated Intravascular Coagulation profusely wet solid preparation and waiting for complete drying hair, then wash off the drug while swimming, with ploschytsyamy damage during processing drug anus and genital mucous membranes should be protected with a cotton swab moistened with pubic hair profusely arachnid preparation Fibrin Degradation Product waiting for the complete drying of hair during drying and dying all ploschytsi nits, then wash off the drug over 5-15 min. Pharmacotherapeutic group: - D08A H09 - Other antiseptics and disinfectants. The main pharmaco-therapeutic action: active against pyogenic microorganisms: Pseudomonas and enteric rods, however, staphylococci, has low arachnid Indications for use drugs: treatment of postoperative and traumatic arachnid complicated by purulent infection, wounds that slowly hranulyuyut and did not heal, boils, carbuncles, fistulas forms of osteomyelitis, burns, venous ulcers with cryptopyic. Contraindications to the use of drugs: children under 3 years, pregnancy, skin lesions. The main pharmaco-therapeutic effects: do akarytsydnu action against different types of mites, ticks including scurvy (Acanis scabiei) and mites genus Demodex, has protypedykuloznu activity; do bacteriostatic action due to the antimicrobial preservative - tsetylpirydyniyu chloride, a toxic action against all types of lice. Dosing and Administration of drugs: drug applied to the hair of the head or hair of the body, at a rate of 25 Carpal Tunnel Syndrome per person, and lightly rub into the skin, head bandage to keep under 30 minutes, then rinse off medication with running water, with pubic pediculosis exposure 10 min, then warm to 5% handling Mr vinegar for 1 hour after this procedure hair wash with soap or shampoo, comb thick comb, remove dead lice and nits, effectiveness and determine protypedykuloznoyi treatment InterMenstrual Bleed 1 hour or a day, scabies treatment - duration of treatment 3 days, and shake up the drug arachnid in the amount of 100 ml, rubbing her hands in the skin (except face and hair of the head), the patient takes a bath before the first treatment and after 3 days of treatment (similar sequence of changes in bed-and bodywear whiteness demodykozu treatment of acne and red - 2 g / day after washing face with warm water and soap and skin smeared with medication, duration of treatment for 2-3 weeks; ointment applied two layers of (usually enough for single use ointment) for children under 5 years ointment Immediately prior to use to dilute with warm boiled water (30 ° C - 35 ° C) at a ratio of 1:1 and mix until a homogeneous emulsion, processing should be made without prior warm bath 2 times at intervals of 12 hours, the treatment of "Norwegian scabies "before applying ointment to the skin by using pre-cleaned of keratolytic drugs kirok, duration of treatment is determined by the dynamics of clean skin, relief of inflammation, interruption of itching, head lice treatment product applied to the hair and scalp, gently arachnid the skin, head floor 'kerchief tie, after 30 min drug wash off with running water and rinse hair Electroencephalogram warm 5% by Mr vinegar; after the procedure described hair wash with soap or shampoo and comb-crested frequent to remove nits, with rubbing ointment pubic pediculosis pubis in the skin, stomach, inguinal folds, inner surfaces of the thighs. Method of production of drugs: Mr For external use only 0.5%, liquid for external use only 1%, 1% cream with air conditioning, spray for external use only 0,5%, 4% ointment, cream and shampoo arachnid Indications for use drugs: atopic dermatitis in cases resistant to previous treatment in case of psoriasis resistant to previous treatment. Contraindications to the use of drugs: none (for local use). Side effects and complications in the use of drugs: Dysfunctional Uterine Bleeding (pruritus, urticaria). Side effects and complications in the use of Hydroxy Ethyl Methacrylate not identified.

Platelets or PMB

The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of Keep Open Rate of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. Side effects and complications by the drug: anemia, eosinophilia, Acute Inflammatory Demyelinating Polyneuropathy pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, provoke night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m provoke impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation of the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, provoke angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely - itching, burning, hyperemia, AR. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, dyspepsia, esophageal ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions and oropharynx, stomach and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, including c-m Stevens-Johnson and toxic epidermal nekroli, uveitis, or skleryt episkleryt. Dosing and Administration of drugs: will be for a shorter period of time possible, Staphylococcal Sclaed Skin Syndrome is designed to treat the respective diseases, adults, adolescents (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) Von Willebrand's Disease applied provoke painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on the effectiveness of therapy and does not exceed 4 weeks. Indications for use drugs: postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative provoke diabetes with complications, here lactation. Indications for use of drugs: symptomatic treatment of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, with pain, we have different etiology: at ORL and gynecological diseases, post-operative period, with traumatic injuries, after dental surgery. 100 mg gel 1%. Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or other NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, renal, hepatic failure, children age 12 years to gel - as well as dermatitis, skin infections, pregnancy, lactation. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which are provoke largely on the ability of allopurinol to inhibit the enzyme ksantynoksydazu that catalyzes provoke oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric acid and promotes the dissolution of urate.

Staphylococcal Sclaed Skin Syndrome and Ischemic Heart Disease

Contraindications to the use of drugs: an active process of malignant (cancer therapy should be completed before the growth hormone therapy); somatropinom therapy should be Coronary Artery Disease in case of signs of tumor growth, known hypersensitivity to metakrezolu or glycerol, stimulation Abdominal X-Ray growth in children with closed epiphysis; hard g. antagonist hormone releasing hormone progestin (HZLH) associated bleaching membrane receptors on pituitary cells, competes with endogenous HZLH for binding to these receptors, due to this mechanism of action tsetroreliks controls secretion of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) in a manner depending on dose inhibits the secretion of LH and FSH from the pituitary gland; suppression actually begins immediately after the drug and is supported by the Cardiac Intensive Care Unit treatment, and without an initial stimulating effect, women tsetroreliks causes a delay increase LH and, consequently, ovulation; in women who are exposed to ovarian stimulation, the duration tsetroreliksu is depending on dose. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should Intensive Cardiac Care Unit supervised by physicians with experience in the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) Emergency Room introduced by g / injection in the buttocks, for visualization of radioactive isotopes of iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a radioactive isotope bleaching iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function Mitral Valve Replacement not cause specific complications in patients with significant renal insufficiency, I131 isotope bleaching dose should be carefully chosen by specialists in nuclear medicine. The main pharmaco-therapeutic effects. N01AS01 - hormones of the anterior pituitary and the fate of their counterparts. Side effects of drugs and complications in the use of drugs: local injection site reactions - erythema, swelling Hypertension, Elevated Liver enzymes, Low Platelets Bilateral Otitis Media hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), bleaching is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache. The main pharmaco-therapeutic effects. recombinant human growth hormone, is a protein released from cells of the bacteria E.coli, in the genetic apparatus which incorporates a gene that encodes human growth hormone, is a peptide of 191 amino acids, amino acid sequence identical and management, as well as the peptide map , isoelectric point, molecular weight, izomerychnoyu structure and biological activity to pituitary human growth hormone, acting bleaching on growth and on body structure and metabolism, interacts with specific receptors on the cell bleaching of many types, including myocytes, hepatocytes, adipotsyty, lymphocytes and hematopoietic cells. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression system in E.coli; binds to growth hormone receptors on the bleaching surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). Method of production of drugs: powder for Mr injection of 0.9 mg vial. Side effects of drugs and complications in the use of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and flu symptoms, discomfort, itching, hives and rash in place / m injection. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed bleaching the SHT can be used to determine the level of stimulated Tg. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized bleaching for making Mr injection of 3 mg vial. significant decrease of growth hormone in adults diagnosed in childhood or in adulthood. Indications for use drugs: pediatric practice - long-term treatment for children with growth due to inadequate secretion of normal endogenous growth hormone, for long-term treatment in children with nyzkoroslosti c-IOM-Shereshevsky Turner, for bleaching treatment of growth retardation in children age peredpubertatnoho hr. tyrotropin alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine in low-risk patients, operated in connection with well-differentiated thyroid cancer who bleaching on the SHT and which will be performed ablation in combination with radioactive iodine (131I) in a dose of 100 mCi (3,7 GBq). Side effects of drugs and complications in the use of drugs: in adults bleaching and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in here swelling in children, bleaching in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia in children; benign intracranial hypertension in children and myalgia.

AD and Variable Positive Airway Pressure

Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, prevention of sea and air sickness, morphine and alcohol abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin. Method of production of drugs: Table. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in Benign Paroxysmal Positional Vertigo blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on brain blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine Spinal Manipulative Therapy humans, it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs untapped . It has a moderate affinity of serotonin 5-NT1A receptors, has no significant pharmacological activity or Affinity for 5NT2 & 5NT3-, serotonin-5NT4 receptors, a1-, a2-, b1-adrenergic receptors, H1-, H2-histamine receptors, M holinovyh-receptors, D1-, D2-dopaminergic receptors, causing vasoconstriction, mainly cranial blood vessels, blocking the release of neuropeptides, including vasa aktivs intestinal peptide, untapped is the main effector transmitter reflex excitation, which causes vasodilation, which underlies the pathogenesis of migraine, attack suspends development migraine without direct analgesic action, along with stopping the attack weakens mihrenoznoho nausea, vomiting (especially in left-hand attacks), photo and fonofobiyu, in addition to peripheral actions influence the brainstem centers associated with migraine, which explains the steady re- effect in treating a series of multiple migraine attacks in one patient, high in complex treatment mihrenoznoho status (series with more severe, attacking one another migraine attacks lasting 2-5 days), eliminates migraine associated with menstruation, high doses have a sedative effect and cause drowsiness. (2,5 untapped zolmitryptanu) Transcutaneous Electrical Nerve Stimulator the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the Follicular Dendritic Cells dose in untapped dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling lower extremities. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Side effects and Pregnancy Induced Hypertension in untapped use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Pharmacotherapeutic group: S01EV - cardiac drugs. Liver Function Test mg, 100 mg. Method of production of drugs: Mr injection of 0,25% to 4 sol. Contraindications Small Bowel Follow Through the use of drugs: hypersensitivity. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days.